This peer-reviewed oral hygiene & prevention article summarizes clinical evidence from BMC oral health (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient outcomes, or clinical protocols.
Abstract
BACKGROUND: Dental caries remains one of the most prevalent non-communicable diseases worldwide, imposing substantial health and economic burdens despite conventional preventive measures such as fluoride use and oral hygiene. Increasing recognition of caries as a dysbiosis-driven biofilm disease has prompted exploration of microbiota-modulating strategies, including probiotics, prebiotics, synbiotics, and postbiotics. AIM: This systematic review and meta-analysis aimed to compare the effectiveness of probiotics, prebiotics, synbiotics, and postbiotics in preventing dental caries and to assess associated microbiological and ecological outcomes. METHODS: A comprehensive search of MEDLINE, Embase, Cochrane CENTRAL, Web of Science, Scopus, trial registries, and grey literature was performed from inception to 2024. Randomized controlled trials and controlled clinical trials assessing caries outcomes or validated intermediate endpoints were included. Data extraction and risk-of-bias assessments were conducted independently by two reviewers. Random-effects meta-analysis was applied to estimate pooled risk ratios (RRs) with subgroup analyses by age, strain, delivery format, and duration. Certainty of evidence was graded using GRADE methodology. RESULTS: Twenty-five studies met inclusion criteria; 18 randomized trials contributed to meta-analysis. Probiotics demonstrated the strongest clinical signal. In pediatric populations (12 RCTs; n ≈ 2,300), probiotics significantly reduced new or progressive caries (RR = 0.80; 95% CI, 0.68–0.95). Adult probiotic trials (6 RCTs; n ≈ 1,100) showed no significant benefit (RR = 0.95; 95% CI, 0.80–1.12). Evidence for prebiotics (n = 3), synbiotics (n = 2), and postbiotics (n = 3) was sparse, heterogeneous, and largely limited to microbiological endpoints, including reductions in Streptococcus mutans and favorable plaque pH shifts. Reported adverse events were mild and infrequent. DISCUSSION: Probiotics, particularly Lactobacillus rhamnosus and L. reuteri delivered via lozenges or dairy products, show moderate-certainty evidence for modest caries prevention in children. Other microbiota-modulating approaches remain promising but under-investigated, constrained by small sample sizes, heterogeneous interventions, and lack of standardized outcomes. CONCLUSION: Probiotics represent a safe and acceptable adjunct to conventional preventive strategies in pediatric populations, though benefits are modest. Prebiotics, synbiotics, and postbiotics require further validation through large, long-term, strain-specific RCTs with standardized clinical endpoints and mechanistic analyses to clarify their role in caries prevention.
Key takeaway
Key takeaway: This review-level evidence helps clinicians interpret the consistency and strength of available clinical findings in this topic area.
Introduction from full text
Dental caries is a biofilm-dependent disease that continues to challenge conventional preventive strategies, such as fluoride application and mechanical plaque removal. Biofilm-targeted therapies (BTT), including probiotics, photodynamic therapy, enzymatic treatments, and natural compounds, represent promising alternatives to disrupt pathogenic biofilms effectively. However, the available evidence remains fragmented, with inconsistent methodologies and limited clinical data hindering comprehensive conclusions.
Peer-reviewed source
Chuan Lu, Shuai Zhang, Guang Hong
BMC oral health. 2026
DOI: 10.1186/s13643-025-02921-0
PMID: 41593561
PubMed: https://pubmed.ncbi.nlm.nih.gov/41593561/
Image: Diana Polekhina (Unsplash)
Oral Hygiene & Prevention 16 June 2026
This peer-reviewed oral hygiene & prevention article summarizes clinical evidence from BMC oral health (2026). It focuses on findings that may help dental professionals evaluate treatment...
Oral Hygiene & Prevention 03 June 2026
This peer-reviewed oral hygiene & prevention article summarizes clinical evidence from BMC oral health (2026). It focuses on findings that may help dental professionals evaluate treatment...
Oral Hygiene & Prevention 20 May 2026
This peer-reviewed oral hygiene & prevention article summarizes clinical evidence from BMC oral health (2026). It focuses on findings that may help dental professionals evaluate treatment...
Oral Hygiene & Prevention 06 May 2026
This peer-reviewed oral hygiene & prevention article summarizes clinical evidence from BMC oral health (2026). It focuses on findings that may help dental professionals evaluate treatment...
Implantology 10 July 2026
This peer-reviewed implantology article summarizes clinical evidence from Clinical oral implants research (2026). It focuses on findings that may help dental professionals evaluate treatment...
Aligners F22® is an Edra professional dentistry reference focused on clinical practice, education and treatment planning.
Products 10 July 2026
Planmeca introduces two dental units designed to support modern clinical workflows through different concepts and use cases.
News 10 July 2026
BIOLASE, a MegaGen company and global leader in dental laser technology, today announced a significant investment in its Corona, California, manufacturing operations, underscoring
News 10 July 2026
Led by Farhad Boltchi, DMD, and Darin Dichter, DMD, the program provides a real-time look at the clinical decisions that shape anterior implant outcomes
Editorials 10 July 2026
From California to Canada: CU Anschutz School of Dental Medicine at ADEA, GRC and IADR 2026
The CU Anschutz School of Dental Medicine will showcase a wide breadth of educational innovation, faculty development, clinical training and research at three major gatherings this